Why Zoetis Inc. and Cambrex Corporation Were Today's 2 Big Losers

In this video from Tuesday's Market Checkup, Motley Fool health-care analyst David Williamson takes investors through the biggest investing stories in the health care space today.

In this segment, David takes a look at two of the day's losers from the world of health care. Animal health powerhouse Zoetis (NYSE: ZTS  ) fell 5% today, after it reported fourth-quarter results that came in slightly ahead of analyst estimates, at $0.36 per share versus an estimate of $0.34. However, the news that had shares falling was the company's guidance for 2014. With a midpoint of $1.51 in per-share 2014 earnings, guidance was 10 cents lighter per share than analysts had hoped, and the stock took a haircut as a result.

Small-cap active pharmaceutical ingredient maker Cambrex (NYSE: CBM  ) is today's other loser. While there was no further clarity regarding rumors over the a possible deal for Cambrex regarding the hepatitis C drug Sovaldi, the more important factor today was that the company released guidance for 2014, which, like Zoetis, was also lower than estimates.

How best for investors to play the volatile biotech space?
The best way to play the biotech space is to find companies that shun the status quo and instead discover revolutionary, groundbreaking technologies. In The Motley Fool's brand-new free report "2 Game-Changing Biotechs Revolutionizing the Way We Treat Cancer," find out about a new technology that big pharma is endorsing through partnerships, and the two companies that are set to profit from this emerging drug class. Click here to get your copy today.


Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On February 12, 2014, at 2:01 AM, talexanderyu wrote:

    Thank you! A great article--concise and useful. Have had my eye on Zoetis for a while, and appreciated just getting a straightforward snippet on why shares dropped as they did.

    Wish you guys would do many more of these, just helping us keep our pulses on whats going on a bit better. I'm watching at least 2 dozen companies and its hard to keep up with the news for each one every day.

    Motley Fool publishes a lot of filler, but this was helpful.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2835281, ~/Articles/ArticleHandler.aspx, 9/22/2014 4:25:32 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement